Lp(a): an interloper into the fibrinolytic system?
Miles
L A
LA
Committee on Vascular Biology, Research Institute of Scripps Clinic, La Jolla, California 92037.
Plow
E F
EF
D000595:Amino Acid Sequence; D001054:Apolipoproteins A; D001483:Base Sequence; D001667:Binding, Competitive / Q000502:physiology; D001798:Blood Proteins / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000097:blood; D005337:Fibrin / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D037181:Lectins, C-Type; D017270:Lipoprotein(a); D008074:Lipoproteins / Q000502:physiology*; D008239:Lysine / Q000378:metabolism; D008969:Molecular Sequence Data; D015394:Molecular Structure; D010958:Plasminogen / Q000378:metabolism; D010960:Plasminogen Activators / Q000502:physiology; D011485:Protein Binding; D011956:Receptors, Cell Surface / Q000378:metabolism; D055293:Receptors, Urokinase Plasminogen Activator
D001054:Apolipoproteins A; D001798:Blood Proteins; D037181:Lectins, C-Type; D017270:Lipoprotein(a); D008074:Lipoproteins; C524898:PLAUR protein, human; D011956:Receptors, Cell Surface; D055293:Receptors, Urokinase Plasminogen Activator; C048648:tetranectin; D005337:Fibrin; D005340:Fibrinogen; D010958:Plasminogen; D010960:Plasminogen Activators; D008239:Lysine